Eiger BioPharmaceuticals, Inc. ( EIGR) - Stock Earnings
Stock symbol EIGR is outdated, potentially delisted? Maybe it is available on other exchange?
EIGR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -22.8 million USD | 4.1 million USD |
| 2023Q2 | -20.7 million USD | 4.6 million USD |
| 2023Q3 | -18.0 million USD | 3.2 million USD |
EIGR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -33.9 million USD | 12.1 million USD |
| 2022 | -96.8 million USD | 13.5 million USD |
| 2023 | -86.6 million USD | 14.7 million USD |
EIGR
Price: $1.72
52 week price:
Earnings Per Share: -58.50 USD
P/E Ratio: -0.10
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 759300
Ebitda: -8.8 millionMarket Capitalization: 2.6 million